Skip to main content
Clinical Trials/ACTRN12618001573246
ACTRN12618001573246
Not yet recruiting
Phase 2

A prospective study investigating the efficacy and toxicity of definitive chemoradiation and immunotherapy (CRIO) in locally and/or regionally advanced cutaneous squamous cell carcinoma

Metro North Hospital and Health Service0 sites15 target enrollmentSeptember 20, 2018

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
skin cancer
Sponsor
Metro North Hospital and Health Service
Enrollment
15
Status
Not yet recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 20, 2018
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials